-
1
المؤلفون: Mina Nicole Händel, Isabel Cardoso, Cecilie von Bülow, Jeanett Friis Rohde, Anja Ussing, Sabrina Mai Nielsen, Robin Christensen, Jean-Jacques Body, Maria Luisa Brandi, Adolfo Diez-Perez, Peyman Hadji, Muhammad Kassim Javaid, Willem Frederik Lems, Xavier Nogues, Christian Roux, Salvatore Minisola, Andreas Kurth, Thierry Thomas, Daniel Prieto-Alhambra, Serge Livio Ferrari, Bente Langdahl, Bo Abrahamsen
المساهمون: Rheumatology, AII - Inflammatory diseases, AMS - Musculoskeletal Health, AMS - Tissue Function & Regeneration, Medical Informatics
المصدر: BMJ (Clinical research ed.), 381:e068033. BMJ Publishing Group
Händel, M N, Cardoso, I, von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J-J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ (Clinical research ed.), vol. 381, e068033, pp. e068033 . https://doi.org/10.1136/bmj-2021-068033
BMJ. BMJ Publishing Group
Händel, M N, Cardoso, I, Von Bülow, C, Rohde, J F, Ussing, A, Nielsen, S M, Christensen, R, Body, J J, Brandi, M L, Diez-Perez, A, Hadji, P, Javaid, M K, Lems, W F, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, S L, Langdahl, B & Abrahamsen, B 2023, ' Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials ', BMJ, vol. 381, e068033 . https://doi.org/10.1136/bmj-2021-068033مصطلحات موضوعية: Osteoporotic Fractures/prevention & control, Network Meta-Analysis, General Medicine, Postmenopause, Diphosphonates/adverse effects, Osteoporosis, Postmenopausal/complications, Humans, Spinal Fractures, Female, Bone Density Conservation Agents/adverse effects, Denosumab/adverse effects, Risk Reduction Behavior, Osteoporosis/drug therapy, Randomized Controlled Trials as Topic, Receptor, Parathyroid Hormone, Type 1
وصف الملف: application/pdf
-
2
المؤلفون: Olivier Lamy, Mohamed Faouzi, Thierry Buclin, Peter Burckhardt
المساهمون: The Swiss Denosumab Study Group
المصدر: Journal of bone and mineral research, vol. 36, no. 9, pp. 1717-1728
Journal of Bone and Mineral Researchمصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, Osteoporosis, 030209 endocrinology & metabolism, OSTEOPOROSIS, Bone resorption, Fractures, Bone, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Bone Density, Internal medicine, medicine, Humans, Orthopedics and Sports Medicine, Bone Density Conservation Agents, Denosumab/adverse effects, Diphosphonates/adverse effects, Retrospective Studies, ANTIRESORPTIVES, DENOSUMAB, FRACTURE RISK ASSESSMENT, STATISTICAL METHODS, Bone mineral, Hip fracture, Diphosphonates, business.industry, Retrospective cohort study, Original Articles, medicine.disease, Discontinuation, 030104 developmental biology, Denosumab, Original Article, business, medicine.drug
وصف الملف: application/pdf
-
3
المصدر: Nederlands Tijdschrift voor Geneeskunde. 162(21)
مصطلحات موضوعية: Diphosphonates/administration & dosage, Bone/chemically induced, Bone Density, Spinal Fractures/chemically induced, Humans, Osteoporosis, Female, Bone Density Conservation Agents/adverse effects, Osteoporosis/complications, Postmenopausal/drug therapy, Denosumab/adverse effects, Fractures
URL الوصول: https://explore.openaire.eu/search/publication?articleId=dris___01423::18799e54a432206952b0cc98154dda14
https://research.rug.nl/en/publications/6ae86351-405e-4ad5-96b6-e9d785e3af70 -
4
المصدر: Nederlands Tijdschrift voor Geneeskunde. 162(21)
مصطلحات موضوعية: Diphosphonates/administration & dosage, Bone/chemically induced, Bone Density, Spinal Fractures/chemically induced, Humans, Osteoporosis, Female, Bone Density Conservation Agents/adverse effects, Osteoporosis/complications, Postmenopausal/drug therapy, Denosumab/adverse effects, Fractures
URL الوصول: https://explore.openaire.eu/search/publication?articleId=dris___00893::96ab8985716a06a3af7cfd42f84152e5
https://www.ntvg.nl/artikelen/het-denosumab -dilemma -
5
المؤلفون: Daniel Prieto-Alhambra, Irene Petersen, Antonella Delmestri, Cyrus Cooper, T P van Staa, Samuel Hawley, Muhammad Javaid, Elisa Martín-Merino, S Khalid, Ana Llorente-García, Arturo Álvarez-Gutiérrez, Andrew Judge
المساهمون: Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
المصدر: Martín-Merino, E, Petersen, I, Hawley, S, Álvarez-Gutierrez, A, Khalid, S, Llorente-Garcia, A, Delmestri, A, Javaid, M K, Van Staa, T P, Judge, A, Cooper, C & Prieto-Alhambra, D 2018, ' Risk of venous thromboembolism among users of different anti-osteoporosis drugs : a population-based cohort analysis including over 200,000 participants from Spain and the UK ', Osteoporosis International, vol. 29, no. 2, pp. 467–478 . https://doi.org/10.1007/s00198-017-4308-5
Osteoporosis International, 29(2), 467. Springer Londonمصطلحات موضوعية: Male, Endocrinology, Diabetes and Metabolism, Thiophenes/adverse effects, Cohort Studies, 0302 clinical medicine, Strontium ranelate, Teriparatide, 80 and over, Electronic health records, 030212 general & internal medicine, Bone Density Conservation Agents/adverse effects, Denosumab/adverse effects, Aged, 80 and over, Alendronate, Bone Density Conservation Agents, Diphosphonates, United Kingdom/epidemiology, Hazard ratio, Alendronate/adverse effects, Venous Thromboembolism, Pharmacoepidemiology, Middle Aged, Primary care, Diphosphonates/adverse effects, Denosumab, Cohort, Spain/epidemiology, Female, medicine.drug, Cohort study, Venous thromboembolism, medicine.medical_specialty, 030209 endocrinology & metabolism, Thiophenes, Risk Assessment, Bazedoxifene, 03 medical and health sciences, Primary Health Care/methods, Teriparatide/adverse effects, Internal medicine, medicine, Humans, Anti-osteoporosis medication, Risk Assessment/methods, Aged, Primary Health Care, business.industry, United Kingdom, Spain, Venous Thromboembolism/chemically induced, business
وصف الملف: application/pdf
Full text from British Medical Journal